Copyright
©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 108714
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.108714
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.108714
Table 1 Research targeted astrocyte and its signaling pathway, protein kinases, receptors, and channels for diabetic neuropathy treatment
Name of treatment | Target treatment | Target cells | Mediator/cells, receptor regulated via activation | Molecular mechanisms | Ref. |
MK-801 | Protein kinase-MAPKs | Microglia, neuron | NMDA receptor | Protein kinases | Daulhac et al[91], 2006 |
PARP inhibitor, 1,5-isoquinolinediol | Enzyme- poly (ADP-ribose) polymerase (PPAR) | Microglia, neuron, astrocytes | Isoprostane, 8-hydroxy-2′-deoxyguanosine excretion, 4-hydroxynonenal adduct accumulation | Enzymes | Lupachyk et al[92], 2011 |
MK-801 | Receptor-NMDA receptor | Neuron, astrocytes | ERK1/2, NMDA receptor, nNOS, iNOS | Receptor-related mechanisms | Dauch et al[93], 2012 |
U0126 | Extracellular signal-regulated protein kinase | Neuron, astrocytes | p-ERK, Iba1, GFAP, NeuN | Protein kinases | Xu et al[94], 2014 |
levetiracetam | Channels-calcium channel | Microglia, astrocytes | CD11b and GFAP expression | Ion channels | Reda et al[95], 2016 |
Lycopene | Gap junction- Connexin43 | Astrocytes | GFAP and TNF-α expression | Gap junctions | Zhang et al[96], 2016 |
Dexmedetomidine | Receptor-α2 adrenergic agonist | Astrocytes, microglial | Iba1, GFAP, IL-1β, TNF-α, glutamate | Receptor-related mechanisms | Lu et al[97], 2017 |
Mesenchymal stem/stromal cells | Cytokines-IL-1β, and TNF-α | Astrocytes, microglia | Iba1, GFAP, catalase, glutathione peroxidase, superoxide dismutase, Nrf2, MDA, IL-1β, TNF-α | Cytokines signaling | Evangelista et al[98], 2018 |
Duloxetine | Receptor-Serotonin noradrenaline reuptake inhibitor | Astrocytes, microglia | CD11, GFAP, sciatic mRNA expression of NGF | Receptor-related mechanisms | Tawfik et al[99], 2018 |
Dexmedetomidine | Signaling pathway-Wnt 10a/β-Catenin | Astrocytes | TNF-α, IL-1β, GFAP, Wnt 10a and β-catenin | Signaling pathways | Zhong et al[100], 2018 |
Ammoxetine | Receptor-Serotonin and norepinephrine reuptake inhibitors | Astrocytes, microglia | Iba1, GFAP, MAPKs, NF-κβ, IL-1β, TNF-α, IL-6 | Receptor-related mechanisms | Zhang et al[101], 2018 |
Hydrogen sulfide donor GYY4137 | Cytokines-proinflammatory mediators | Astrocytes, microglia | Iba1, GFAP, neuron, IL-1β, IL-6, TNF-α | Cytokines signaling | Shayea et al[102], 2020 |
Curcumin | Protein kinases-c-Jun N-terminal kinase | Astrocytes, neurons | p-JNK expression | Protein kinases | Park et al[103], 2021 |
Fluorocitrate | Selective inhibitor of astrocyte activation | Astrocytes | GFAP expression | Selective inhibitors | Liu et al[104], 2022 |
Semaglutide | GLP-1 receptor agonists | Astrocytes, microglia | HbA1c, AGEs, Iba1, GFAP, IL-1β, IL-6, TNF-α | GLP-1 receptor agonists | Lee et al[105], 2024 |
- Citation: Haris K, Long I. Role of astrocytes in diabetic neuropathy: Review of their involvement in disease mechanisms. World J Diabetes 2025; 16(10): 108714
- URL: https://www.wjgnet.com/1948-9358/full/v16/i10/108714.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i10.108714